US Patent Issued to BEIJING WELLGENE on July 8 for "Recombinant oncolytic virus composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,304, issued on July 8, was assigned to BEIJING WELLGENE COMPANY LTD. (Beijing).

"Recombinant oncolytic virus composition and use thereof" was invented by Chao Tian (Beijing), Xiaopeng Li (Beijing), Chunyang Sun (Beijing), Hua Zhou (Beijing), Jiajia Liu (Beijing) and Jingshu Zhao (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a recombinant oncolytic virus composition, comprising a first recombinant oncolytic virus and a second recombinant oncolytic virus. Both the first and second recombinant oncolytic viruses comprise a herpes simplex virus vector and an exogenous gene, the exogenous gene is encoded from one of cytokine, a monocl...